These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6656700)

  • 21. Dose parameters of 125I and 192Ir seed sources.
    Weaver KA; Smith V; Huang D; Barnett C; Schell MC; Ling C
    Med Phys; 1989; 16(4):636-43. PubMed ID: 2770636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the development of consensus values of reference dosimetry parameters for interstitial brachytherapy sources.
    Chan GH; Nath R; Williamson JF;
    Med Phys; 2004 May; 31(5):1040-5. PubMed ID: 15191290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy.
    Heysek RV; Gwede CK; Torres-Roca J; Cantor A; Kelley S; Saini AS; Pow-Sang J
    Brachytherapy; 2006; 5(4):244-50. PubMed ID: 17118318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo dosimetry with a linear MOSFET array to evaluate the urethra dose during permanent implant brachytherapy using iodine-125.
    Bloemen-van Gurp EJ; Haanstra BK; Murrer LH; van Gils FC; Dekker AL; Mijnheer BJ; Lambin P
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1266-72. PubMed ID: 19665317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose rate determination for 125I seeds.
    Chiu-Tsao ST; Anderson LL; O'Brien K; Sanna R
    Med Phys; 1990; 17(5):815-25. PubMed ID: 2233567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality assurance of I-125 seeds for prostate brachytherapy using an imaging plate.
    Furutani S; Saze T; Ikushima H; Oita M; Ozaki K; Kishida Y; Takegawa Y; Nishitani H
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):603-9. PubMed ID: 16966003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physical and technical quality assurance and radiation protection in transperineal interstitial permanent prostate brachytherapy with 125-iodine seeds].
    Kaulich TW; Lamprecht U; Paulsen F; Lorenz J; Maurer U; Loeser W; Bichler KH; Nüsslin F; Bamberg M
    Strahlenther Onkol; 2002 Dec; 178(12):667-75. PubMed ID: 12491054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rigid phantom dosimetry of brachytherapy sources, with special reference to 125-I].
    Arcovito G; Piermattei A; Bacci C; Pittella G; Castagnola M
    Radiol Med; 1985 Jun; 71(6):426-32. PubMed ID: 4070702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of the effective attenuation coefficients with model 6711-(125)I seeds.
    Sun C; Cheng CW; Lutz W
    Med Phys; 1996 Apr; 23(4):545-7. PubMed ID: 9157268
    [No Abstract]   [Full Text] [Related]  

  • 30. Feasibility study of using MOSFET detectors for in vivo dosimetry during permanent low-dose-rate prostate implants.
    Cygler JE; Saoudi A; Perry G; Morash C; E C
    Radiother Oncol; 2006 Sep; 80(3):296-301. PubMed ID: 16905209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
    Abboud F; Scalliet P; Vynckier S
    Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The ID-03 X-ray dosimeter for monitoring the radiation parameters of X-ray equipment in roentgenography].
    Vladimirov LV; Kozlov AA
    Med Tekh; 2002; (5):22-4. PubMed ID: 12512278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a high-resolution room temperature Si detector for use in clinical health physics.
    Anderson D; Hartman R; Gilmore R; Pruitt D
    Health Phys; 1985 Nov; 49(5):953-7. PubMed ID: 4066353
    [No Abstract]   [Full Text] [Related]  

  • 34. Relative biological effectiveness enhancement of a 125I brachytherapy seed with characteristic x rays from its constitutive materials.
    Taschereau R; Roy R; Pouliot J
    Med Phys; 2002 Jul; 29(7):1397-402. PubMed ID: 12148718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scintigraphic detection of 125I seeds after permanent brachytherapy for prostate cancer.
    Kono Y; Kubota K; Mitsumoto T; Tanaka A; Ishibashi A; Kobayashi K; Ito K; Itami J; Kanemura M; Minowada S
    J Nucl Med; 2008 Apr; 49(4):541-5. PubMed ID: 18344427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Realisation of the absorbed dose to water for I-125 interstitial brachytherapy sources.
    Schneider T; Selbach HJ
    Radiother Oncol; 2011 Sep; 100(3):442-5. PubMed ID: 21924788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic edema in 125I permanent prostate implants: dynamical dosimetry taking volume changes into account.
    Leclerc G; Lavallée MC; Roy R; Vigneault E; Beaulieu L
    Med Phys; 2006 Mar; 33(3):574-83. PubMed ID: 16878561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium as an adjunct to radioiodine therapy in Graves' disease for prolonging the intrathyroidal effective half-life of radioiodine. Useful or not?
    Dunkelmann S; Künstner H; Nabavi E; Eberlein U; Groth P; Schümichen C
    Nuklearmedizin; 2006; 45(5):213-8; quiz N51-2. PubMed ID: 17043732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calibration procedures for seeds preloaded in cartridges.
    Brame RS; Cohen GN; Zaider M
    Med Phys; 2006 Aug; 33(8):2765-72. PubMed ID: 16964852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.